CD4 and relapsing-remitting multiple sclerosis: Possible involvement in the development and progression of SCC (Squamous Cell Lung Carcinoma Tissues). miR-193a is strongly upregulated in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.